Industry landscapes
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE IRELAND EDITION 2026

Ireland’s
life sciences industry,
in focus.

The companies, capital and talent shaping life sciences in Ireland. Find the leaders. Understand the segments. See where the activity is.

Snapshot: Funding in USD
Illustrated cover for Life Sciences Industry Landscape of Ireland
IE
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Life Sciences illustration
MEET THE COMPANIES

Explore Ireland’s life sciences leaders

24 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Life Sciences company highlights in Ireland, snapshot 3 September 2026
Company
Horizon Therapeuticshorizontherapeutics.com$347.12M2,190
Avadel Pharmaceuticalsavadel.com$326.1M74
Normax Biomednormaxbiomed.com$302.6M
Juvenescencejuvlabs.com$289.89M38Financial figure available in RadarView in Radar
Jazz Pharmaceuticalsjazzpharma.com$272M8 roles831Financial figure available in RadarView in Radar
GC Aestheticsgcaesthetics.com$232.81M259Financial figure available in RadarView in Radar
Iterum Therapeuticsiterumtx.com$183.41M7Financial figure available in RadarView in Radar
Nuritasnuritas.com$155.15M45
Alkermesalkermes.com9 roles1,775Financial figure available in RadarView in Radar
Selio Medicalseliomedical.com3 roles
Perfuzeperfuze.com2 roles30
Teckroteckro.com2 roles161
Luminate Medicalluminatemed.com1 roles15
NUA Surgicalnuasurgical.com1 roles5
Neurent Medicalneurentmedical.com1 roles48
Active Ironactiveiron.com20
Aerogenaerogen.com200
Amarinamarincorp.com365Financial figure available in RadarView in Radar
CYGENICAcygenica.com5Financial figure available in RadarView in Radar
Cosmo Pharmaceuticalscosmopharma.com319
GH Researchghres.com32
Gigigigisupplements.com
Kneat Solutionskneat.com261
Prothenaprothena.com127Financial figure available in RadarView in Radar
24 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Company discovery

Recorded evidence only
THE KEY SIGNALS

Life Sciences industry KPIs in Ireland

A few useful ratios bring the size of this ecosystem into perspective.

3 September 2026
Hiring participation5.6%

19 of 340 tracked companies have open roles.

Funding participation47.1%

160 of 340 tracked companies have a recorded round.

Top 3 funding share22.8%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$2.43M

Midpoint of 338 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 22.8% of disclosed capital, while 52.9% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How Ireland life sciences has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

Ireland life sciences
$0$183.17M$366.33M$549.5M$732.66M2016: $245.11M20162017: $86.89M20172018: $642.68M20182019: $384.66M20192020: $322.66M20202021: $257.38M20212022: $630.58M20222023: $174.09M20232024: $125.03M20242025: $324.36M2025
View the numbers
Annual life sciences funding and company formation in Ireland
YearFunding (USD)FoundedRaising
2016$245.11M2332
2017$86.89M2922
2018$642.68M1835
2019$384.66M1542
2020$322.66M1636
2021$257.38M826
2022$630.58M933
2023$174.09M616
2024$125.03M210
2025$324.36M114
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • Horizon Therapeutics8.1%
  • Avadel Pharmaceuticals7.6%
  • Normax Biomed7.1%
  • Other companies77.2%

Funding by stage

407 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel87 21.4%
Series A–B90 22.1%
Series C+ / PE12 2.9%
Grants, debt & other218 53.6%

Recent recorded rounds

Latest recorded rounds · USD
1 rounds

Swipe or scroll horizontally to browse.

Seed03/2026
Gigi $1.74M

Backed by Vestra Partners.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Expand panel +

Annual accounts availability

No reviewed exact national-ID connector has yet been qualified for Ireland; this is a checked implementation boundary, not evidence that filings are absent.; No reviewed exact national-ID connector has yet been qualified for Ireland; this is a checked implementation boundary, not evidence that filings are absent.

INSIDE THE INDUSTRY

The Ireland life sciences market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Enterprise tech242
Medical devices115
Healthtech64
Enterprise software52
Biopharmaceuticals49
Consumer digital44
Deep tech40
Saas18
In vitro diagnostics17
Healthtech saas15
Iot in healthcare15
Nutritional formula12

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Enterprise tech

The largest measured segment in this report snapshot.

242companies
7.0%have hiring activity

17 companies hiring · $3.76B disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

Physical commerce180
E-commerce - product131
Subscription101
Fee-for-service54
Commission on transaction9
Advertising5
E-commerce - service3
Sponsorship1
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 10 dated reports
Funding roundsghres.com ↗

today announced the pricing of an underwritten offering in the United States of 6,527,779 of its ordinary shares at an offering price of $18.00 per share for total gross proceeds of approximately $117.5 million

Mergers & acquisitionsamrytpharma.com ↗

Back in 2023, the company penned a takeover of rare disease–focused Amryt Pharma and the now approved Filsuvez topical gel for up to $1.25 billion upfront.

Funding roundsluminatemed.com ↗

Galway-based medtech company Luminate Medical, which raised $21m.

Mergers & acquisitionsalkermes.com ↗

The parties entered into a definitive agreement on 22 October 2025 (as amended on 18 November 2025) which provided for the acquisition to occur by way of scheme of arrangement through the High Court of Ireland. Avadel Pharmaceuticals plc and Alkermes plc are each biopharmaceutical companies headquartered in Ireland. The transaction completed on 12 February 2026.

Funding roundscosmopharma.com ↗

Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced the successful completion of a private placement of 937,086 treasury shares. The shares were placed with Capital Group’s SMALLCAP World Fund.

Funding roundsbluedropmedical.com ↗

Bluedrop Medical, a Galway-based medtech company, has secured a €1m investment from Enterprise Ireland as the semi-state agency bolsters its backing for companies seeking to scale globally.

Funding roundsproverummedical.com ↗

ProVerum secured €68.6 million to advance a minimally invasive urology treatment

Mergers & acquisitionsvivasuremedical.com ↗

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk‑reward sharing partnerships, today announced that it expects to receive up to $21 million in cash proceeds in connection with the acquisition of Vivasure, an Ireland‑based company pioneering next‑generation technology for percutaneous vessel closure, by Haemonetics Corporation (NYSE: HAE, “Haemonetics”), which closed on January 9, 2026.

Mergers & acquisitionsavadel.com ↗

the board of directors of Avadel Pharmaceuticals plc (Nasdaq: AVDL), a public limited company incorporated in Ireland (the “Company” or “Avadel”) and the board of directors of Alkermes plc, a public limited company incorporated in Ireland (“Alkermes”), reached agreement on the terms of an offer for the Company by Alkermes, pursuant to which Alkermes will acquire the entire issued and to be issued ordinary share capital of the Company

Funding roundsnemysisltd.com ↗

The proceeds from the issue of shares will be used to accelerate the commercialization of the Company's novel and innovative oral iron supplement, Iron Hydroxide Adipate Tartrate ("IHAT"), expand Nemysis' broader product portfolio, and support the completion of development and initial commercial manufacturing of Endoprotease 40, the Company's oral enzymatic therapy designed to break down gluten and prevent symptomatic exposure in both celiac and non-celiac gluten-sensitive individuals.

Full recorded event mix

Top 10 categories among 355 recorded events in the 24-month window.

Earnings
112
Funding rounds
72
Leadership moves
41
Mergers & acquisitions
40
IPO activity
21
Contracts
14
Company announcements
11
Regulatory
10
Fda Approval
9
Capital infusions
7
6 activity cards

Swipe or scroll horizontally to browse.

Leadership moves

6 tracked people moves

Alkermes ↗
Richard Pops

Retirement Previously CEO

Alkermes ↗
Blair Jackson

Promotion Chief Executive Officer

Dane Boog, MBA

Promotion associate director of omnichannel and patient marketing, oncology

Thomas Riga

Appointment Chief Business Officer

Ted W. Love, MD

Appointment Board Member

Alkermes ↗
Joshua Reed

Appointment Senior Vice President and Chief Financial Officer

Workforce actions

3 companies with reported reductions

Prothena ↗

91 rolescash runway

Alkermes ↗

122 rolescost reduction

Aerogen ↗

32 rolescost reduction

Litigation

6 tracked suits

Company
Avadel CNS Pharmaceuticals v jazz pharmaceuticals

intellectual property disputeCivil · Settled

Company
alkermes v teva

patent infringementPatent · Filed

Earnings pulse

Reported company results in the recorded window.

11companies
144period observations
10.0%median reported growth

Median across 43 reported growth observations; companies may contribute multiple periods.

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
chiesi groupAmryt Pharma ↗Completed2026-04-29$1.2B
AlkermesAvadel Pharmaceuticals ↗Completed2026-02-12Not stated in snapshot
Haemonetics CorporationVivasure Medical ↗Announced2026-01-12$21.0M
amgenHorizon Therapeutics ↗Completed2026-01-01$27.8B
lundbeckAvadel Pharmaceuticals ↗Announced2025-11-21Not stated in snapshot
H Lundbeck A/SAvadel Pharmaceuticals ↗Announced2025-11-15Not stated in snapshot

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

1 postings in the preceding 12 months. The full 3-posting snapshot covers 2 employers.

Expand panel +

Most advertised job titles

Professor And Head Of School Of Pharmacy And Biomolecular Sciences2
0 internship postings

0 tracked postings mention remote work.

The seniority mix

2 postings specify a level.

lead
2
unspecified
1

Skills employers mention

Top skills across 3 tracked postings in the available jobs snapshot.

Pharmaceutical Engineering
2
Gmp
1
Biotechnology
1
Supply Chain
1
Life Sciences
1
Chemistry
1
Chemical Engineering
1
THE PEOPLE BUILDING THE FIELD

Founders and leaders

231 founders and chief executives across 166 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

23 profiles with education records.

University of Limerick
3
Stanford University
3
Technological University Dublin
3
Imperial College London
2
University of Cambridge
2
Yale University
1
Stanford Business School
1
University of Chicago
1

Prior employers

4 profiles with prior-work records.

Microsoft
2
Paypal
1
Intel
1
Bain
1

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

198,562 articles in the measured 12-month window.

Expand panel +
198,562articles in the measured year
31,417articles in 2026Q1
80.1%positive tone in the latest complete year

News volume trends

Life Sciences coverage across Ireland · articles per complete quarter

032,06364,12696,189128,2532021Q2: 26,3112021Q22021Q3: 53,0422021Q4: 25,5442022Q1: 28,6812022Q2: 25,7002022Q22022Q3: 24,5812022Q4: 29,4102023Q1: 30,3132023Q2: 31,7392023Q22023Q3: 30,2342023Q4: 26,9242024Q1: 30,4662024Q2: 32,5762024Q22024Q3: 30,1992024Q4: 28,8062025Q1: 39,8752025Q2: 24,5532025Q22025Q3: 111,5242025Q4: 23,7212026Q1: 31,4172026Q1
View quarterly article counts
QuarterArticles
2021Q226,311
2021Q353,042
2021Q425,544
2022Q128,681
2022Q225,700
2022Q324,581
2022Q429,410
2023Q130,313
2023Q231,739
2023Q330,234
2023Q426,924
2024Q130,466
2024Q232,576
2024Q330,199
2024Q428,806
2025Q139,875
2025Q224,553
2025Q3111,524
2025Q423,721
2026Q131,417

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
64,268 positive · 1,269 neutral · 45,480 negative
2022
67,088 positive · 1,993 neutral · 39,059 negative
2023
75,426 positive · 2,168 neutral · 41,295 negative
2024
80,784 positive · 2,583 neutral · 38,411 negative
2025
159,792 positive · 2,593 neutral · 36,994 negative

Leading coverage topics

Life Sciences coverage across Ireland · ranked by full-period article count.

International Sports Competitions25,250 articles in the full recorded period
4,502 recent · 5,775 prior
Championship Event Highlights10,344 articles in the full recorded period
2,082 recent · 2,008 prior
Sports Coaching Strategies8,035 articles in the full recorded period
1,242 recent · 1,315 prior
International Political Relations7,777 articles in the full recorded period
1,451 recent · 1,664 prior
Olympic Games Coverage7,205 articles in the full recorded period
1,105 recent · 1,786 prior
Sports History And Legacy Stories6,541 articles in the full recorded period
1,258 recent · 1,188 prior
Youth Sports Development Programs5,939 articles in the full recorded period
812 recent · 926 prior
Nationalism And Sovereignty Debates5,748 articles in the full recorded period
543 recent · 568 prior
Political Biographies And Memoirs4,908 articles in the full recorded period
375 recent · 224 prior
Sports Injury Reports4,900 articles in the full recorded period
981 recent · 726 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

Life Sciences coverage across Ireland

KeywordRecentPriorChange
study overseas413200106%
overseas study371181105%
semester abroad354172106%
stock performance26915574%
sports legislation18889111%
international programs1859791%
border enforcement practices17033415%
bowl game matchups16279105%
comex gold analysis15777104%
world cup women1538874%
odi world cup255790-68%
icc world cup227730-69%
odi tactics336691-51%
limited overs cricket336653-49%
odi cricket323637-49%

Event and signal lenses

Life Sciences coverage across Ireland

All complete annual cohorts shown
Rising

Regulatory Risk

127,245 classified articles

odi world cup, limited overs cricket, odi tactics

39.9% critical · 32.8% positive
Flat

Funding Momentum

30,323 classified articles

on-campus living, residential colleges, student accommodation

32.3% critical · 42.0% positive
Flat

Growth

36,303 classified articles

tax policy execution, tax expenditure oversight, gdp growth rate

33.4% critical · 45.0% positive

Life Sciences coverage across Ireland. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Life Sciences research is working on

53,147 papers in the recorded worldwide scope.

Expand panel +
53,147papers
53,147worldwide comparison pool
India-affiliated papers

Research orientation

Descriptive
21,347
Promising
16,144
Breakthrough
7,516
Problem-identifying
4,407
Cautionary
1,880
Comparative
1,302
Critical
551

Contribution mix

Empirical
25,959
Reviews
19,786
Methods-led
5,939
Position pieces
1,146
Theoretical
317

Tone counts: 42,568 positive · 8,415 neutral · 2,164 negative.

Common problems researchers identify
4,958 papers · 9.3% of this field
  • Agriculture506 papers
  • Antibiotic resistance341 papers
  • Production233 papers
  • Human health225 papers
  • Sustainability221 papers
  • Antimicrobial216 papers
  • Food safety192 papers
  • Food security181 papers

Landmark: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term prob

Cautions
1,880 papers · 3.5% of this field
  • Agriculture96 papers
  • Food safety80 papers
  • Gene66 papers
  • Antibiotic resistance61 papers
  • Toxicity56 papers
  • Population55 papers
  • Production52 papers
  • Human health51 papers

Landmark: Genomic responses in mouse models poorly mimic human inflammatory diseases

Opportunities
23,660 papers · 44.5% of this field
  • Gene1,464 papers
  • Agriculture827 papers
  • Fermentation719 papers
  • Antimicrobial639 papers
  • In vivo588 papers
  • Population535 papers
  • Transcriptome527 papers
  • Downregulation and upregulation520 papers

Landmark: Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Leading institutions

Harvard University
86,693
Howard Hughes Medical Institute
74,901
Chinese Academy of Sciences
61,376
Centre National de la Recherche Scientifique
49,087
Cornell University
42,772
Stanford University
38,500

Leading researchers

Ahmad Almilaji
14,302
Reiki Nishimura
13,204
Tomofumi Osako
13,204
Yasuyuki Nishiyama
13,204
Rumiko Tashima
13,204
Masahiro Nakano
13,204
Glenn R. Gibson
12,830
Gregor Reid
10,793

Highly cited breakthrough-labelled papers

  • Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity9,015 citations
  • In situ click chemistry generation of cyclooxygenase-2 inhibitors7,514 citations
  • U1 snRNP regulates cancer cell migration and invasion in vitro7,224 citations
  • Comprehensive molecular profiling of lung adenocarcinoma5,754 citations
  • Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signal5,748 citations

Common problems researchers identify

4,503 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Plant Microbiome and BiofertilizersCommon problems researchers identify · 01

Plant Microbiome and Biofertilizers

781 papers

17.3% of this theme group

Researchers discuss microbial roles in soil health, nutrient recycling, and sustainable biofuel feedstock production.

Biofuel (41) · Synthetic biology (53) · Biomass (45) · Biorefinery (28)

A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application

Biofertilizers: An ecofriendly technology for nutrient recycling and environmental sustainability

View research history
YearShare index
202260.6
202359.3
202461.9
202567.0
Food Safety and ProcessingCommon problems researchers identify · 02

Food Safety and Processing

757 papers

16.8% of this theme group

Papers examine microbial risks, processing impacts, and nutritional quality of foods for human health.

Food safety (130) · Food processing (74) · Food products (50) · Human health (90)

Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures

Nutritional quality and processing of plant proteins for healthy and sustainable foods

View research history
YearShare index
202270.2
202372.4
202477.4
202599.2
mRNA and Gene ExpressionCommon problems researchers identify · 03

mRNA and Gene Expression

711 papers

15.8% of this theme group

Studies focus on messenger RNA technologies, gene regulation, and cell‑culture models for therapeutic development.

Messenger RNA (28) · Gene (44) · Cell culture (23) · Gene expression (24)

Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research

Evolution of Approaches to the Development, Life Cycle Control, and Interchangeability of Veterinary Biosimilars Based on Hemoproteins (with

View research history
YearShare index
20222510.1
20232495.8
20242199.0
20251697.8
Crop Nutrition and Food SecurityCommon problems researchers identify · 04

Crop Nutrition and Food Security

693 papers

15.4% of this theme group

Research addresses fertiliser strategies, nutrient‑use efficiency, and breeding approaches to improve crop yields.

Agriculture (208) · Crop (84) · Food security (86) · Germplasm (39)

Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants

Breeding for nutrient use efficiency in crop plants: Mechanistic insights, genetic determinants, and emerging breeding technologies

View research history
YearShare index
20221635.2
20231667.4
20241799.9
20252026.9
Plant Disease ManagementCommon problems researchers identify · 05

Plant Disease Management

691 papers

15.3% of this theme group

Works explore innate immunity, pathogen interactions, and integrated pest‑management tactics for healthier crops.

Fungicide (44) · Integrated pest management (54) · Host (41) · Disease management (32)

Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens

Insect-Borne Plant Pathogens and Their Vectors: Ecology, Evolution, and Complex Interactions

View research history
YearShare index
202227.8
202329.2
202427.8
202537.2
Antimicrobial ResistanceCommon problems researchers identify · 06

Antimicrobial Resistance

447 papers

9.9% of this theme group

Analyses cover resistance patterns in humans, livestock, and the environment and the impact of antimicrobial use.

Antibiotic resistance (301) · Antimicrobial (164) · Antibiotics (126) · Drug resistance (49)

Antimicrobial resistance in humans, livestock and the wider environment

Antimicrobial use and resistance

View research history
YearShare index
2022886.3
2023838.0
2024911.9
2025963.5
Miscellaneous Biological TopicsCommon problems researchers identify · 07

Miscellaneous Biological Topics

423 papers

9.4% of this theme group

A diverse set of papers on biochemical pathways, regulatory mechanisms, and interdisciplinary scientific communication.

Order (19) · NAD+ kinase (11) · Human being (12) · Sodium (11)

Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar

Obiteljska grupna konferencija: prilika za građansko pravosuđe?

View research history
YearShare index
202218.4
202321.9
202417.8
202512.5

Cautions

1,765 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Cellular Stress AssaysCautions · 01

Cellular Stress Assays

379 papers

21.5% of this theme group

Investigations assess oxidative stress, cytotoxicity, and assay reliability in vitro and in vivo.

In vivo (32) · Flow cytometry (16) · In vitro (27) · Oxidative stress (19)

Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells

Cell Painting for cytotoxicity and mode-of-action analysis in primary human hepatocytes

View research history
YearShare index
20221034.9
20231110.3
2024911.7
2025818.5
Genomic Selection in BreedingCautions · 02

Genomic Selection in Breeding

257 papers

14.6% of this theme group

Papers discuss theory, practice, and future directions for applying genomic selection to crops and livestock.

Agriculture (45) · Selection (26) · Production (28) · Trait (16)

Genomic selection in plant breeding: from theory to practice

Future Directions for Sustainable Poultry Feeding and Product Quality: Alternatives from Insects, Algae and Agro-Industrial Fermented By-Pro

View research history
YearShare index
20221437.3
20231478.4
20241637.4
20251817.4
Feed Additives and HealthCautions · 03

Feed Additives and Health

245 papers

13.9% of this theme group

Research evaluates natural bioactive compounds as feed additives and their effects on animal performance and health.

Feed additive (27) · Animal feed (28) · Feed conversion ratio (32) · Health benefits (30)

Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production

The impact of substituting animal with plant protein foods in adults’ self-selected diets on environmental, nutritional, and health outcomes

View research history
YearShare index
202222.2
202320.9
202417.3
202518.2
Food Contaminants and SafetyCautions · 04

Food Contaminants and Safety

240 papers

13.6% of this theme group

Studies review chemical contaminants, safety assessments, and regulatory considerations for food products.

Food safety (66) · Hygiene (21) · Contamination (29) · Food contaminant (20)

Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters

Insect-derived food colorants: Chemistry, applications, safety, and regulatory perspectives

View research history
YearShare index
202291.3
202389.1
202495.4
2025105.8
DNA Damage and RepairCautions · 05

DNA Damage and Repair

239 papers

13.5% of this theme group

Works focus on mechanisms of DNA damage, repair pathways, and their relevance to disease.

Gene (41) · DNA damage (26) · DNA repair (13) · Gene expression (20)

Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations

Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer

View research history
YearShare index
20222415.6
20232417.4
20242125.5
20251613.8
Antibiotic Use in AgricultureCautions · 06

Antibiotic Use in Agriculture

206 papers

11.7% of this theme group

Analyses examine antibiotic applications in animal production and co‑selection of resistance traits.

Antibiotic resistance (59) · Antibiotics (47) · Antimicrobial (38) · Bacteria (26)

Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses

Co-Selection of Resistance to Antibiotics, Biocides and Heavy Metals, and Its Relevance to Foodborne Pathogens

View research history
YearShare index
2022886.3
2023838.0
2024911.9
2025963.5
Pesticide Resistance ManagementCautions · 07

Pesticide Resistance Management

199 papers

11.3% of this theme group

Papers explore biological control options and modeling approaches to mitigate pesticide resistance.

Pesticide (34) · Integrated pest management (21) · PEST analysis (30) · Biological pest control (20)

The use of fungal entomopathogens as endophytes in biological control: a review

Managing pesticide resistance by changing the applied dose: a modeling analysis incorporating pesticide persistence and including low-dose m

View research history
YearShare index
202266.9
202365.3
202466.9
202575.8

Opportunities

22,038 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Antibody and Fluorescence TechnologiesOpportunities · 01

Antibody and Fluorescence Technologies

1,044 papers

17.4% of this theme group

Research highlights novel antibodies, fluorescent labeling, and flow cytometry for in‑vivo imaging and diagnostics.

Antibody (70) · In vivo (81) · Fluorescence (40) · Flow cytometry (50)

Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom

Preparation, Characterization, and Binding Mechanism of Nanobodies Targeting Multiple Serotypes of <i>Salmonella</i>

View research history
YearShare index
2022561.4
2023615.1
2024467.1
2025455.3
Gene Regulation for TherapyOpportunities · 02

Gene Regulation for Therapy

1,032 papers

17.2% of this theme group

Studies investigate gene knockdown, apoptosis control, and cell‑growth modulation for disease treatment.

Downregulation and upregulation (106) · Apoptosis (80) · Gene knockdown (103) · Cell growth (43)

Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc

RasGRP3 Promotes RAP1B Activity to Inhibit Endothelial Inflammation and Alleviate Atherosclerosis in High-Fat Diet-Fed ApoE−/− Mice

View research history
YearShare index
2022364.0
2023394.7
2024257.4
2025261.8
Functional Plant‑Based FoodsOpportunities · 03

Functional Plant‑Based Foods

878 papers

14.6% of this theme group

Papers explore health‑promoting ingredients, antioxidants, and sustainable protein sources in functional foods.

Health benefits (78) · Functional food (61) · Ingredient (48) · Antioxidant (69)

Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives

PLANT-BASED PROTEINS: SOURCES, EXTRACTION METHODS AND FUNCTIONAL PERSPECTIVES FOR THE SUSTAINABLE FOOD INDUSTRY

View research history
YearShare index
202226.7
202326.2
202427.1
202545.2
Epigenetics and RNA BiomarkersOpportunities · 04

Epigenetics and RNA Biomarkers

823 papers

13.7% of this theme group

Research delves into DNA methylation patterns, RNA markers, and their roles in disease diagnostics.

Gene (164) · DNA methylation (60) · Messenger RNA (76) · DNA damage (55)

Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders

Stimuli-ResponsiveFusion of Binary-Star IntelligentDNA System for the Signal-On Amplification Detection of Cancer-RelatedmiRNA

View research history
YearShare index
20222397.7
20232377.6
20242114.7
20251613.7
Novel Antimicrobials and BiocontrolOpportunities · 05

Novel Antimicrobials and Biocontrol

809 papers

13.5% of this theme group

Works present plant‑derived antimicrobials, resistance‑modifying agents, and postbiotic applications for animal health.

Antimicrobial (126) · Antibiotic resistance (66) · Biological pest control (54) · Bacteria (87)

Plants as sources of new antimicrobials and resistance-modifying agents

Postbiotics: Multifunctional Microbial Products Transforming Animal Health and Performance

View research history
YearShare index
2022524.8
2023510.4
2024554.5
2025649.8
Genetic Improvement of CropsOpportunities · 06

Genetic Improvement of Crops

717 papers

11.9% of this theme group

Studies assess germplasm variability, quantitative trait loci, and selection strategies to boost yield.

Germplasm (71) · Trait (52) · Quantitative trait locus (40) · Selection (53)

Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield

GENETIC VARIABILITY ANALYSIS FOR YIELD AND RELATED TRAITS IN WHEAT (TRITICUM AESTIVUM L.) MUTANT GENOTYPES

View research history
YearShare index
202253.0
202345.3
202439.2
202540.8
Sustainable Biomass and BiofuelsOpportunities · 07

Sustainable Biomass and Biofuels

697 papers

11.6% of this theme group

Research focuses on microbial fermentation, agri‑food by‑products, and biofuel production for a circular economy.

Biomass (67) · Sustainability (77) · Agriculture (102) · Biofuel (35)

Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health

Bioactive Compounds From Agri‐Food By‐Products: Advancements in Environmental Sustainability and Bioeconomic Progress

View research history
YearShare index
20221514.8
20231566.1
20241742.6
20251980.2

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Descriptive40.2%17.7%
Promising30.4%37.4%
Breakthrough14.1%26.1%
Problem-identifying8.3%9.7%
Cautionary3.5%4.3%
Comparative2.4%3.8%
Critical1.0%1.0%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Privacy & surveillanceSARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunities870.21%25 (28.7%)0.21%
Hardware, e-waste & supply chainFate and Transport of Antibiotic Residues and Antibiotic Resistance Genes following Land Application of Manure Waste610.15%4 (6.6%)0.15%
Bias & fairnessGeographic Prevalence Heterogeneity Creates Unavoidable Fairness-Accuracy Trade-offs in Antimicrobial Resistance Predict120.03%2 (16.7%)0.03%
Safety & misusePublic perceptions and information sources on genetically modified organisms in Kenya30.01%3 (100.0%)0.01%
Energy & datacenter footprintIntegration of GWAS and WGCNA Identifies PUE‐Related Gene <i>TaERF112</i> in Wheat10.0%0 (0.0%)0.0%
Water use00.0%0 (%)0.0%
Carbon & emissions of compute00.0%0 (%)0.0%
Labour & data work00.0%0 (%)0.0%
Concentration of compute power00.0%0 (%)0.0%

Research orientation and citation rankings describe the covered collection. Its recorded publication dates do not support an overall publication-volume trend.

Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.

INNOVATION SIGNALS

Who files Life Sciences patents in Ireland

Published patent filings in the recorded source window.

Expand panel +
5,073filings 2016–2025
1,871assignees
666peak annual filings

Filing momentum

01913835747662016: 30220162017: 4342018: 44420182019: 4482020: 55420202021: 6462022: 66620222023: 5092024: 53820242025: 5322025

Who files the most

Prothena Biosciences
858
WUXI Biologics Ireland
502
Wyeth
273
Alimentary Health
225
Janssen Alzheimer Immunotherap
214
Legend Biotech Ireland
207
Nogra Pharma
204
Grifols Worldwide Operations
199
GEOGRAPHIC FOOTPRINT

Where companies are based

Company counts, hiring and disclosed funding across the recorded hubs.

Expand panel +
8 cards

Swipe or scroll horizontally to browse.

UNDERSTAND THE LANDSCAPE

Life Sciences in Ireland: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

Company ecosystem snapshot: 3 September 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon